Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen

Journal of Vascular Research

Volumn 34, Issue 3, 1997, Pages 229-236

  Kauser, Katalin ^a   Rubanyi, Gabor M ^a  

^a BAYER AG   (Germany)

Author keywords

Atherosclerosis; Endothelial nitric oxide synthase; Estrogen; Nitric oxide; Vasculoprotection

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DRUG MECHANISM; GENDER; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN PROCESSING; VASCULAR ENDOTHELIUM;

EID: 0030927817     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159227     Document Type: Article

References (72)

1. Isles CG, Hole DJ, Hawthorne VM, Lever AF: Relation between coronary risk and coronary mortality in women of the Refcw and Paisely survey: Comparison with men, Lancet 1992: 339:702-706.
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizcr FE, Hennekens CH: Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study, N Engl J Med 1991.325: 756-762.
3. Vargas R, Wroblewska B, Hatch J, Grojce M, Foegh M, Ramwell PW: Estradiol inhibition of thymidine uptake in explants of porcine left anterior descending coronary artery, Circulation 1990:82(suppl III):111-572.
4. Orimo A, Inoue S, Ouchi Y, Orimo H: Vascular smooth muscle cells possess estrogen receptor and respond to estrogen, Ann NY Acad Sci 1995;748:592-594.
5. Nakai K, Itoh C, Hotta K, Iloh T, Yoshizumi M, Hiramori K: Estradiol-17ß regulates the induction of VCAM-1 mRNA expression by interleukin-lß in human umbilical vein endothelial cells, Life Sci 1994;54:221-227.
6. Frazier-Jcsscn MR, Kovacs EJ: Estrogen modulation of JE/monocytc chemoattractant pro-tcin-l mRNA expression in murine macrophages, J Immunol 1995;154:1838-1845.
7. Caulin-Glaser T, Watson CA, Pardi R, Bender JR.: Effects of 17f-estradiol on cytokine-induced endothelial cell adhesion molecule expression, J Clin Invest 1996;98:36-42.
8. Maziere C, Ronveaus MF, Salmon S, Santus R, Mazier JC: Estrogen inhibit copper and cell-mediated modification of low density lipoprotein, Atherosclerosis 1991;89:175-182.
9. Nagre-Salvayrc A, Pieraggi M-T, Mabile L, Sal-vayre R: Protective effect of 17ß-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells, Atherosclerosis 1993;99:207-217.
10. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P: Endothelium-independent relaxation of rabbit coronary artery by l7ß-oes-tradiol in vitro, Br J Pharmacol 1991:104: 1033-1037.
11. Gilligan DM, Badar DA, Panza JA, Quyyumi AA, Cannon RO: The effects of estrogen on endothelium-dependent vasodilation in postmenopausal women, Circulation 1993:88:1-79.
12. Kauscr K, Rubanyi GM: 17ß-Estradiol and endothelial nitric oxide synthase, Endothelium 1994:2:203-208.
13. Azuma H, Ishikawa M, Sekizaki S: Endothelium-dependent inhibition of platelet aggregation, Br J Pharmacol 1986:88:411-415.
14. Jonjic N, Jilek P, Bernasconi S, Peri G, Martin-Padura L, Cenzuales S, Dejana E, Mantovani A: Molecules involved in the adhesion and cytotoxicity of activated monocytes on endothelial cells, J Immunol 1992;148:2080-2083.
15. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogencsis and proliferation of cultured rat vascular smooth muscle cells, J Clin Invest 1989:83:1774-1777.
16. Furchgolt RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 1980;228:373-376.
17. Maddox YT, Falcon JG, Ridinger M, Cunard CM, Ramwell PW: Endothelium-dependent gender differences in the response of the rat aorta, J Pharmacol Exp Ther 1987;240:392-395.
18. Stallone JN, Crofton JT, Share L: Sexual dimorphism in vasopressin-induced contraction of rat aorta, Am J Physiol 1991;260:H453-H458.
19. 2+ and Na+, Br J Pharmacol 1992:5:305-310.
20. Hayashi T, Fukuto JM, Ignarro U, Chaudhuri G: Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis, Proc Natl Acad Sci 1992;89:11259-11263.
21. Kauser K, Rubanyi GM: Gender difference in bioassavablc endothelium-derived nitric oxide release from isolated rat aortac, Am J Phvsiol 1994;267:H2311-H2317.
22. Kauser K, Rubanyi GM: Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats, Hypertension 1995; 25:517-523.
23. Gisclard V, Miller VM, Vanhouette PM: Effect of 17ß-estradiol on endothelium-dependent responses in the rabbit, J Pharmacol Exp Ther 1988:244:19-22.
24. Lieberman EH, Gerhard M, Yeung AC, Anderson TJ, Meredith IT, Ganz P, Selwyn AP: Estrogen improves coronary vasomotor responses to acetylcholine in postmenopausal women, Circulation 1993;88:1-79.
25. Bell DR, Rensbcrger HJ, Koritnik DR, Koshy A: Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries, Am J Physiol 1995;268: H377-H383.
26. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moneada S: Induction of calcium-dependent nitric oxide synthases by sex hormones, Proc Natl Acad Sci 1994:91:5212-5216.
27. Kauscr K, Rubanyi GM: 17ß-estradiol attenuates endothelial dysfunction in the aorta of male spontaneously hypertensive rats, J Am Coll Cardiol 1994;295A (abstract).
28. Harrison DG: Endothelial dysfunction in atherosclerosis, Basic Res Cardiol 1994:89 (suppl I):87-102.
29. Kauser K, Sonnenberg D, Mertens H, Werner M, Wilson K, Polokoff R, Vergoña R, Rubanyi GM: Vasculoprotective effect of 17ß-estradiol in high cholesterol-fed, ovaricctomized rabbits, FASEBJ 1995;9:I-A854.
30. Horwitz KB, Horwitz CD: Canine vascular issues are targets for androgens, estrogens, pro-gestins and glucocorticoids, J Clin Invest 1982: 69:750-758.
31. Lin AL, McGill HC, Shain SA: Hormone receptors of the baboon cardiovascular system, Circ Res 1982:50:610-616.
32. Lin AL, Shain SA, Gonzalez R: Sexual dimorphism characterizes steroid hormone modulation of rat aortic steroid hormone receptors, Endocrinology 1986;! 19:296-302.
33. Losordo DW, Kearney M, Kim EM, Jckanows-ki J, Isner JM: Variable expression of the estrogen receptor in the normal and atherosclerotic coronary arteries of premenopausal women, Circulation 1994:89:1501-1510.
34. Colburn P, Buonassisi V: Estrogen-binding sites in endothelial cell cultures, Science 1978; 201:817-819.
35. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A: Estrogen increases endothelial nitric oxide by a receptor-mediated system, Biochem Biophys Res Commun 1995:214:847-855.
36. Sayegh HS, Ohara Y, Havas JP, Peterson TE, Dockery S, Harrison DG: Endothelial nitric oxide synthase regulation by estrogens, Circulation 1993;88:1-80.
37. Schray-Utz B, Zcihcr AM, Busse R: Expression of constitutive NO synthase in cultured endothelial cells is enhanced by 17ß-estradiol, Circulation 1993;88:1-80.
38. Kumar V, Chambón P: The estrogen receptor binds tightly to its responsive element as a ligand-mduccd homodimcr, Cell 1988:55:145-156.
39. Galien R, Evans HF, Garcia T: Involvement of CCAAT/enhanccr-binding protein and nuclear factor-Kß binding sites in interleukin-6 promotor inhibition by estrogens, Mol Endocrinol 1996;10:713-722.
40. Venema RC, Nishida K, Alexander RW, Harrison DG, Murphy TJ: Organization of the bovine gene encoding the endothelial nitric oxide synthase, Biochim Biophys Acta 1994:1218: 413-420.
41. Robinson LJ, Weremowicz S, Morton CC, Michel T: Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene, Genomics 1994:19:350-357.
42. Harrison DG, Venema RC, Amai JF, Inoue N, Ohara Y, Sayegh H, Murphy TJ: The endothelial cell nitric oxide synthase: Is it really consti-tutively expressed? Agents Actions 1995: 45(suppl): 107-117.
43. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintzc TH: Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression, Circ Res 1994:74:349-353.
44. Amct UA, McMillan A, Dinerman JL, Baller-mann B, Lowenslein CJ: Regulation of endothelial nitric-oxide synthase during hypoxia, J Biol Chem 1996:271:15069-15073.
45. Hirata K-I, Miki N, Kuroda Y, Sakoda T, Kawashima S, Yokoyama M: Low concentration of oxidized low-density lipoprotein and lysopl'.osphatidvlcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells, Circ Res 1995; 76:958-962.
46. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T: Up-rcgulation of nitric oxide synthase by estradiol in human aortic endothelial cells, FEBS Lett 1995:36:291-293.
47. Giaid A, Saleh D: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension, N Engl J Med 1995;333:214-221.
48. Yoshizumi M, Perrella MA, Burnett JC, Lee M-E: Tumor necrosis factor downregulatcs an endothelial nitric oxide synthase mRNA by shortening its half-life, Circ Res 1993:73:205-209.
49. Forstermann U, Pollock JS, Schmidtfill S, Heller M, Murad F: Calmodulin-dependent endo-thclium-dcrived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells, Proc Natl Acad Sci USA 1991:88: 1788-1792.
50. Garcie-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC: Targeting of nitric oxide synthase to endothelial cell caveolac via palmitovlation: Implications for nitric oxide signaling, Proc Natl Acad Sci USA 1996:93:6448-6453.
51. Hecker M, Mulsch A, Bassenge E, Forslermann U, Busse R: Subcellular localization and characterization of nitric oxide svnthase(s) in endothelial cells: Physiological implications, Biochem J 1994;299:247-252.
52. Liu J, Garcia-Cardena G, Scssa WC: Biosynthesis and palmitovlation of endothelial nitric oxide synthase: Mutagenesis of palmitovlation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme, Biochemistry 1995:34:12333-12340.
53. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, Michel T: Acylation targets endothelial nitric-oxide synthase to plasmalcmmal cavcolae, J Biol Chem 1996;271:6518-6522.
54. Michel T, Li GK, Busconi L: Phosphorylation and subcellular translocation of endothelial nitric oxide synthase, Proc Natl Acad Sci USA 1993;90:6252-6256.
55. Ayajiki K, Kindermann H, Heckcr M, Fleming I, Busse R: Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells, Circ Res 1996:78:750-758.
56. Rosenkranz-Weiss P, Scssa WC, Milstien S, Kaufman S, Watson CA, Pober JS: Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells, J Clin Invest 1994:93:2236-2243.
57. Rodriquez-Crcspo I, Gerber NC, Ortiz de Montellano PR: Endothelial nitric-oxide synthase: Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydro-biopterin in dimer formation, J Biol Chem 1996;271:11462-11467.
58. Hattori Y, Gross SS: GTP-cyclohydrolase I mRNA is induced by LPS in vascular smooth muscle: Characterization, sequence and relationship to nitric oxide synthase, Biochem Bio-phys Res Commun 1993;195:435-441.
59. Matsui K, Higashi K, Fukunga K, Miyazaki K, Maeyama M, Miyamoto E: Hormone treatments and pregnancy alter myosin light chain kinase and calmodulin levels in rabbit myometrium, J Endocrinol 1983;97:11-16.
60. Martincz-Campos A, Hcmandez RP, Forsbach G, Barrera-Saldana HA: The stimulatory effect of estradiol 17ß on prolactin mRNA is inhibited by anticalmodulin drugs, Life Sci 1991:48: 2475-2485.
61. 2+ in guinea-pig isolated cardiac myocytes, J Pharmacol 1992;106:739-745.
62. Harder DR, Coulson PB: Estrogen receptor and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle, J Cell Physiol 1979;100:375-382.
63. Busse R, Fichtner H, Luckhoff A, Kohlhardt A: Hyperpolarization and increased free calcium in acetylcholine-stimulated endothelial cells, Am J Physiol 1988;255:H965-H969.
64. Durante W, Liao L, Iflikhar I, O’Brien WE, Schafer Al: Differential regulation of ¿-arginine transport and nitric oxide production by vascular smooth muscle and endothelium, Circ Res 1996;78:1075-1082.
65. Amai JF, Clamens S, Pechet C, Negrc-Salvayre A, Allera C, Girolami J-P, Salvayre R, Bayard F: Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production, Proc Natl Acad Sci USA 1996;93:4108-4113.
66. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: Antiatherogenic effects of Jarginine in the hypercholestcrcmic rabbit, J Clin Invest 1992:90:1168-1172.
67. Creager MA, Gallagher SJ, Gircrd XJ, Coleman SM, Dzau VJ, Cooke JP: J-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans, J Clin Invest 1992;90:1248-1253.
68. Drexler H, Zeiher AM, Meinzer K, Just H: Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by Jarginine, Lancet 1991:338:1546-1550.
69. Clarkson P, Adams MR, Powe AJ, Donald AE, McCrcdie R, Robinson J, McCarthy SN, Keech A, Celermajer C, Deanfield JE: Oral L-argirine improves endothelium-dependent dilation in hypercholesterolemic young adults, J Clin Invest 1996;97:1989-1994.
70. Lcfcr AM, Tsao PS, Lefer DJ: Role of endothelial dysfunction in the pathogenesis of rcperfu-sion injury after myocardial ischemia, FASEB J 1991;5:2029-2034.
71. Rubanyi GM, Vanhoutte PM: Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle, Am J Physiol 1986; 250:H815-H821.
72. Furuya K, Chaudhuri G: Estradiol does not influence myocardial Superoxide dismutase activity in rabbits, J Cardiovasc Pharmacol 1993; 22:65-68.